GoodRx Holdings Reports Q4 Non-GAAP EPS $0.09, Revenue $195M
ArchivedVerified|12 articles|2 sources|1 blocks
Detected: Updated: Analyzed:
Reported Facts
Observable data points shared across all narratives
- •GoodRx Holdings announced Non-GAAP EPS of $0.09 for the quarter ending in early 2026.
- •The company generated revenue of $195 million, surpassing analyst estimates by $1.73 million.
- •The earnings report was released on or before February 25, 2026.
- •The revenue beat occurred despite the EPS being exactly in line with expectations.
What Could Happen If...
- ▸If GoodRx Holdings leverages its revenue growth to expand services the company could improve profitability and attract more investors in the healthcare technology market.
Market Exposure
StocksGoodRx Holdings stockUncertain
Revenue beat may support share price, but in-line EPS limits clear upward momentum.
This is not investment advice. Market exposure is based on conditional event analysis.
Key Actors
Organizations
Source Coverage
FINANCE
12 articles
More coverage on this story
- More on GoodRx Holdings
Signals
Single-block coverageLow source diversityHigh source concentration
Related Events
▸Anterix earnings beat by $0.25, revenue topped estimatesArchived▸Jackson Financial Non-GAAP EPS of $6.61 beats by $0.75, revenue of $1.99B beats by $70MArchived▸Sun quarterly profit beats Wall Street forecastsArchived▸ADTRAN beats earnings and revenue estimates in Q4 2025Archived▸Seven Hills Realty Trust earnings beat by $0.02, revenue topped estimates
Primary Sources (12)
FINANCEInvesting.com - NewsPurecycle Technologies Holdings earnings beat by $0.11, revenue fell short of estimatesFINANCESeeking Alpha - Market NewsPRA Group GAAP EPS of $1.46 beats by $0.97, revenue of $326.71M beats by $37.85MFINANCESeeking Alpha - Market NewsMBIA GAAP EPS of -$0.99 beats by $0.03, revenue of $28M beats by $1.5MFINANCE